Amryt Pharma plc logo
Amryt Pharma plc AMYT

Annual report 2021
added 12-23-2023

report update icon

Amryt Pharma plc Net Income 2011-2026 | AMYT

Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.

Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.[1]

It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.

The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.

Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.

It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.

However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.

Annual Net Income Amryt Pharma plc

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1 M -105 M -65.5 M -29.5 M -31.4 M -8.21 M -39.7 M -2.56 M -2.12 M -826 K -3.06 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1 M -105 M -26 M

References

  1. Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.

Net Income of other stocks in the Biotechnology industry

Issuer Net Income Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
-514 M - 2.43 % $ 254 M germanyGermany
ARCA biopharma ARCA biopharma
ABIO
-83.7 M - 1052.0 % $ 415 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-8.37 M - 5.93 % $ 314 M canadaCanada
Albireo Pharma Albireo Pharma
ALBO
-34 M - -0.23 % $ 916 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
-62.9 M - 10.36 % $ 9.8 M usaUSA
I-Mab I-Mab
IMAB
-1.47 B - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
603 M - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
67.3 M - 2.54 % $ 160 B franceFrance
Biophytis SA Biophytis SA
BPTS
-31.2 M - -13.47 % $ 169 M franceFrance
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
-384 M $ 219.89 2.02 % $ 5 B danmarkDanmark
Aptinyx Aptinyx
APTX
-64.8 M - -39.0 % $ 4.57 M usaUSA
Omeros Corporation Omeros Corporation
OMER
-157 M $ 10.41 2.26 % $ 606 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
-5.46 M - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
-8.09 M - -1.52 % $ 24.7 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
98.1 M $ 19.54 1.61 % $ 913 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
-18.4 M - - $ 26.5 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
-38 M - - $ 7.46 M israelIsrael
AgeX Therapeutics AgeX Therapeutics
AGE
-14.8 M - -10.17 % $ 12.2 K usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
-253 M - -24.86 % $ 820 K usaUSA
Atreca Atreca
BCEL
-97.2 M - -11.76 % $ 5.79 M usaUSA
Acasti Pharma Acasti Pharma
ACST
-9.57 M - 4.01 % $ 150 M canadaCanada
BeiGene, Ltd. BeiGene, Ltd.
BGNE
287 M - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
-212 M - - $ 546 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
72.9 M - - - russiaRussia
Cara Therapeutics Cara Therapeutics
CARA
-119 M - -3.03 % $ 260 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
-131 M - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
-26.2 M - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
-48.1 M - -9.65 % $ 45.9 M usaUSA
Processa Pharmaceuticals Processa Pharmaceuticals
PCSA
-13.6 M $ 2.33 - $ 3.05 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
-11.7 M - -52.27 % $ 4.45 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
-221 M $ 1.32 - $ 337 M britainBritain
Phathom Pharmaceuticals Phathom Pharmaceuticals
PHAT
-221 M $ 10.41 3.48 % $ 759 M usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
-78.5 M $ 8.29 1.28 % $ 110 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
-582 M $ 47.2 1.66 % $ 4.24 B schweizSchweiz
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
-11.2 M - -5.98 % $ 34.1 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
-132 M - - $ 3.74 B usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
27.3 M - - $ 2.02 B usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
84.9 M - -4.8 % $ 255 M usaUSA
Enochian Biosciences Enochian Biosciences
ENOB
-178 M - - $ 40.5 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
-155 M - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
-412 M - - $ 867 M germanyGermany
Pliant Therapeutics Pliant Therapeutics
PLRX
-149 M $ 1.31 1.95 % $ 80.4 M usaUSA
PMV Pharmaceuticals PMV Pharmaceuticals
PMVP
-77.7 M $ 1.38 -1.08 % $ 72.5 M usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
-19.8 M - -74.18 % $ 955 K usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
-252 M - - $ 3.67 B usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
-33.5 M $ 4.46 3.48 % $ 855 M canadaCanada
Homology Medicines Homology Medicines
FIXX
29.8 M - 0.77 % $ 53.4 M usaUSA
Akouos Akouos
AKUS
-86.7 M - 0.23 % $ 488 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
-14.7 M - 1.93 % $ 17.4 M usaUSA
Prelude Therapeutics Incorporated Prelude Therapeutics Incorporated
PRLD
-99.5 M $ 3.28 4.97 % $ 252 M usaUSA